It was reported that in-stent thrombotic occlusion occurred.The target lesion was 95% stenosed with mild tortuosity and mild calcification and located in the left superficial femoral artery (sfa).On (b)(6)2021, a ranger drug-coated balloon was used in the left distal sfa.A non-bsc sent was used in the proximal sfa.On (b)(6)2022, an eluvia drug-coated stent was placed in the left sfa and popliteal artery.A non-bsc drug-coated balloon was used for post-dilation.On (b)(6) 2022, thrombotic occlusion was observed between the non-bsc stent and the eluvia stent in the sfa.On (b)(6) 2022, the target limb was amputated.On (b)(6) 2022, the patient died.The cause of was multiple cerebral infarctions, unrelated to amputation of the target limb.Per the physician assessment, the patient death was not to lower extremity treatments or devices such as eluvia and ranger.
|